Results 121 to 130 of about 1,852,959 (299)

Predicting behavior [PDF]

Nature Neuroscience, 2003
openaire   +2 more sources

Interpreting prediction market prices as probabilities [PDF]

While most empirical analysis of prediction markets treats prices of binary options as predictions of the probability of future events, Manski (2004) has recently argued that there is little existing theory supporting this practice.
Eric Zitzewitz, Justin Wolfers
core  

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Retrieval-Based Factorization Machines for Human Click Behavior Prediction. [PDF]

Comput Intell Neurosci, 2022
Tang Y, Wang S, Huang Y, Zhao X, Zhao W, Duan Y, Wang X.   +6 more
europepmc   +1 more source

Customer behavior prediction

, 2023
Ζούμε στην εποχή που η επιστήμη της μηχανικής μάθησης ανθίζει καθημερινά για να δώσει λύσεις σε κάθε είδους επιχειρησιακή ανάγκη. Οι ανάλυση δεδομένων έρχεται να δώσει απαντήσεις και κατευθύνσεις σε στρατηγικές που για πολλά χρόνια παίρνονταν εμπειρικά.
openaire   +1 more source

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

Molecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon, Dong Young Kim, Yuna Kim, Uk‐Il Kim, Jae‐Sung Kim   +4 more
wiley   +1 more source

TN-GAN-Based Pet Behavior Prediction through Multiple-Dimension Time-Series Augmentation. [PDF]

Sensors (Basel), 2023
Kim H, Moon N.
europepmc   +1 more source

Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver

Molecular Oncology, EarlyView.
Meta‐transcriptome analysis identified FGF19 as a peptide enteroendocrine hormone associated with colorectal cancer prognosis. In vivo xenograft models showed release of FGF19 into the blood at levels that correlated with tumor volumes. Tumoral‐FGF19 altered murine liver metabolism through FGFR4, thereby reducing bile acid synthesis and increasing ...
Jordan M. Beardsley, Michael W. Rohr, Joseph A. Goode, Sai Preethi Nakkina, Jignesh G. Parikh, Deborah A. Altomare   +5 more
wiley   +1 more source

Multiagent off-screen behavior prediction in football. [PDF]

Sci Rep, 2022
Omidshafiei S, Hennes D, Garnelo M, Wang Z, Recasens A, Tarassov E, Yang Y, Elie R, Connor JT, Muller P, Mackraz N, Cao K, Moreno P, Sprechmann P, Hassabis D, Graham I, Spearman W, Heess N, Tuyls K.   +18 more
europepmc   +1 more source

Identification of serum protein biomarkers for pre‐cancerous lesions associated with pancreatic ductal adenocarcinoma

Molecular Oncology, EarlyView.
This work identified serum proteins associated with pancreatic epithelial neoplasms (PanINs) and early‐stage PDAC. Proteomics screens assessed genetically engineered mice with abundant PanINs, KPC mice (Lox‐STOP‐Lox‐KrasG12D/+ Lox‐STOP‐Lox‐Trp53R172H/+ Pdx1‐Cre) before PDAC development and also early‐stage PDAC patients (n = 31), compared to benign ...
Hannah Mearns, Jaclyn S. Long, Sergio Lilla, Kelly Hodge, Marcus J. G. W. Ladds, Colin Nixon, Paula Fernández‐Palanca, Sara Zanivan, Pilar Acedo, Stephen P. Pereira, Kevin M. Ryan   +10 more
wiley   +1 more source